Resources

For more information or an introduction to any of these companies, e-mail sbecker@mcguirewoods.com or call (800) 417-2035. National trade associationsAccreditationAnesthesia staffing and managementBack-office management, outsourcing and accountingBilling, coding and collectingCataract outsourcingConsultation and brokerageCredentialingFinanceGroup purchasing organizationsHealth information technology providers Home health Hospital consulting Imaging Management, consulting and strategyManagement, development and equity firmsMedical devices – Surgical surplus […]

Advertisement
Resource type
All
Topics

Filling an open physician role costs more than $500,000. Yet only 39% of healthcare organizations have a formal retention policy and most aren’t using retirement benefits as the differentiator they could be. The problem is that traditional 401(k) plans offer…

Presented by:

Presented by

An underrecognized, genetically inherited risk factor may be quietly accelerating cardiovascular disease in patients you’re already treating — and routine workups won’t catch it. Lipoprotein(a), or Lp(a), has an emerging and increasingly documented role in aortic stenosis and peripheral arterial…

On Demand

Presented by:

Presented by
Presenters:
  • Dr. Marc P. Bonaca MD, MPH, FACC, FAHA, Executive Director of Colorado Prevention Center, Aurora, CO, USA Director of Vascular Research, Tenured Professor of Medicine, University of Colorado Anschutz, Aurora, CO, USA Chair of the AHA PAD Collaborative Past Chair of the ACC Vascular Disease Section Leadership Council
  • Nishant Shah, MD, Assistant Professor, Medicine and Cardiovascular Disease Prevention Lead for the Duke Health System Remote Lipid Monitoring Program Clinical lead in the implementation of Inclisiran across Duke Health System DCRI for a study that evaluates the effectiveness of PCSK9 inhibitors in the Prevention of Cardiovascular Disease

Health system C-suites are under pressure from every direction: margin compression, workforce strain, fragmented technology and a pace of change that legacy operating models were never built to handle. This curated e-book brings together Becker’s reporting and industry thought leadership…

Presented by:

Presented by

Most hospitals’ vendor credentialing programs were built to protect clinical spaces, especially the operating room. But the operating room isn’t where most third-party personnel actually go. Environmental services, food and nutrition staff, biomedical technicians and facilities contractors move through patient…

Presented by:

Presented by

Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…

On Demand

Presented by:

Presented by
Presenters:
  • Howard S. Weintraub, MD, FACC, FAHA, FASPC, Clinical Professor of Medicine, NYU Grossman School of Medicine  Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
  • Leslie J. Donato, Ph.D., D(ABCC), Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic

Controlled substance waste is one of the most overlooked cost centers in hospital pharmacy. Each waste event represents not just a lost dose, but lost nursing time, compliance overhead and real diversion risk. A recent multi-site study quantified the problem:…

On Demand

Presented by:

Presented by
Presenters:
  • Matthew Gimbar, PharmD
  • Paul Stranges, PharmD, MSHI, BCACP, AE-C, FCCP
  • John Hertig, PharmD, MS, CPPS, FASHP, FFIP
Advertisement